Yıl: 2005 Cilt: 11 Sayı: 6 Sayfa Aralığı: 635 - 639 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Erken doğan retinopatisi

Öz:
Erken doğan retinopatisi (EDR) çocukluk çağının önde gelen ve önlenebilir körlük nedenlerindendir. Neovasküler ve proliferatif bir hastalık olan EDR erken doğum ve düşük doğum ağırlığına ek olarak oksjen tedavisi ile ilişkilendirilmektedir. Bu makalede EDR'nin insidansı; retina damarlarının gelişimi, EDR'nin histopatolojisi ve risk faktörleri; uluslararası EDR sınıflandırması; hastalığın taranması ile mevcut ve gelişen tedavi yöntemleri tartışılmıştır.
Anahtar Kelime: Vasküler endoteliyal büyüme faktör A İnsülin-benzeri büyüme faktörü I Prematüre retinopatisi

Konular: Genel ve Dahili Tıp

Retinopathy of prematurity

Öz:
Retinopathy of prematurity (ROP) is a leading and potentially avoidable cause of blindness in pediatric population. ROP is a retinal neovascular and proliferative disorder of premature infants associated with prematurity and low birth weight related with receiving oxygen therapy. In this article, we discuss the data of ROP incidence; the vascular development of the retina, the histopathology and risc factors of ROP; the international classification of ROP, screening of the disease, current and developing treatment strategies of ROP.
Anahtar Kelime: Vascular Endothelial Growth Factor A Insulin-Like Growth Factor I Retinopathy of Prematurity

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Gibson DL, Sheps SB, UH SH, et al. Retinopathy of prematurity-induced blindness: birthweight-specific survival and the new epidemic. Pediatrics 1990; 86:405-12.
  • 2. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991;98:1628-40.
  • 3. Terry TL. Extreme prematurity and fibroblastic overgrowth of-persistent vascular sheath behind each crystalline lens :preliminary report. Am J Ophthalmol 1942; 25:203-4.
  • 4. Clemett R, Darlow B. Results of screening low-birth-weight infants for retinopathy of prematurity. Curr Opin Ophthalmol.1999; 10:155-63.
  • 5. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-9.
  • 6. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1:1024-8.
  • 7. Pierce E, Foley E; Lois E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.Arch Ophthalmol 1996; 114:1219-28.
  • 8. Hellstrom A, Engström E, Hard A-L, et al. Postnatal serum insulin-like growth factor 1 deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003; 112:1016-20.
  • 9. Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry,severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed.2001; 84:106-10.
  • 10.Kennedy KA, Fielder AR, Hardy RJ, Tung B, Gordon DC,Reynolds JD; LIGHT-ROP Cooperative Group. Reduced lighting does not improve medical outcomes in very low birth weight infants. J Pediatr 2001; 139:527-31.
  • 11.Does elevated peak bilirubin protect from retinopathy of prematurity in very low birthweight- infants. Milner JD, Aly HZ,Ward LB, El-Mohandes A. J Perinatol 2003; 23:208-11.
  • 12.Hosono S, Ohno T, Kimoto H, et al. No clinical correlation between bilirubin levels and severity of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2002; 39:151-6.
  • 13.Chen Y, Leske DA, Zhang S, Karger RA, LanierWL, Holmes JM. Duration of acidosis and recovery determine preretinal neovascularization in the rat model of acidosis-induced retinopathy. Curr Eye Res 2002; 24:281-8.
  • 14.Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984; 102:1130-4.
  • 15.Ibarra MS, Capone A Jr. Retinopathy of prematurity and anterior segment complications. Ophthalmol Clin North Am 2004; 17:577-82.
  • 16.Reynolds JD, Dobson V, Quinn GE et al. CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 2002; 120:1470-6.
  • 17.Larsson E, Holmstrom G. Screening for retinopathy of prematurity: evaluation and modification of guidelines. Br J Ophthalmol 2002; 86:1399-402.
  • 18.The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. 1:primary outcomes. Pediatrics 2000; 105:295-310.
  • 19.Mills MD. STOP-ROP results suggest selective use of supp­lemental oxygen for prethreshold ROP. Arch Ophthalmol 2000;118:1121-2.
  • 20.Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder AR. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med 1998; 338:1572-6.
  • 21.Phelps DL, Lakatos L, Watts JL. D-Penicillamine for preventing retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev 2001; 1 CD001073.
  • 22.Rota R, Riccioni T, Zaccarini M, et al. Capogrossi MC.Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med 2004; 6:992-1002.
  • 23.Yaman A, Berk T, Özkan H, Kaynak S: Erken doğan retinopatisi ve tedavide laserin yeri. TOD Ankara Şubesi 22.Oftalmoloji Kursu Oftalmolojide Laser 2002:135-50.
  • 24.Eugene Y. J. Ng BSc1, Brian P, et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years. Ophthalmology 2002; 109:928-34.
  • 25.Hinz BJ, de Juan E Jr, Repka MX. Scleral buckling surgery for active stage 4A retinopathy of prematurity. Ophthalmology.1998; 105:1827-30.
  • 26.Capone A Jr, Trese MT. Lens-sparing vitreous surgery for fractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology 2001; 108:2068-70.
  • 27.Trese MT, Droste PJ. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology 1998; 105:992-7.
  • 28.Mintz-Hittner HA, O'Malley RE, Kretzer FL Longterm form identification vision after early, closed, lensectomy-vitrectomy for stage 5 retinopathy of prematurity. Ophthalmology 1997; 104:454-9.
APA ONARAN Z, TANER P (2005). Erken doğan retinopatisi. , 635 - 639.
Chicago ONARAN ZAFER,TANER Pelin Erken doğan retinopatisi. (2005): 635 - 639.
MLA ONARAN ZAFER,TANER Pelin Erken doğan retinopatisi. , 2005, ss.635 - 639.
AMA ONARAN Z,TANER P Erken doğan retinopatisi. . 2005; 635 - 639.
Vancouver ONARAN Z,TANER P Erken doğan retinopatisi. . 2005; 635 - 639.
IEEE ONARAN Z,TANER P "Erken doğan retinopatisi." , ss.635 - 639, 2005.
ISNAD ONARAN, ZAFER - TANER, Pelin. "Erken doğan retinopatisi". (2005), 635-639.
APA ONARAN Z, TANER P (2005). Erken doğan retinopatisi. Medical Network Klinik Bilimler ve Doktor, 11(6), 635 - 639.
Chicago ONARAN ZAFER,TANER Pelin Erken doğan retinopatisi. Medical Network Klinik Bilimler ve Doktor 11, no.6 (2005): 635 - 639.
MLA ONARAN ZAFER,TANER Pelin Erken doğan retinopatisi. Medical Network Klinik Bilimler ve Doktor, vol.11, no.6, 2005, ss.635 - 639.
AMA ONARAN Z,TANER P Erken doğan retinopatisi. Medical Network Klinik Bilimler ve Doktor. 2005; 11(6): 635 - 639.
Vancouver ONARAN Z,TANER P Erken doğan retinopatisi. Medical Network Klinik Bilimler ve Doktor. 2005; 11(6): 635 - 639.
IEEE ONARAN Z,TANER P "Erken doğan retinopatisi." Medical Network Klinik Bilimler ve Doktor, 11, ss.635 - 639, 2005.
ISNAD ONARAN, ZAFER - TANER, Pelin. "Erken doğan retinopatisi". Medical Network Klinik Bilimler ve Doktor 11/6 (2005), 635-639.